Answer to Question 1
2,3,4
Rationale 1: While obesity may be contributing to the patient's hypertension, use of propranolol (Inderal) is not contraindicated.
Rationale 2: Beta blockers may cause hyperglycemia or hypoglycemia and may mask the symptoms of hypoglycemia in patients with diabetes.
Rationale 3: Beta blockers may cause significant bronchial constriction.
Rationale 4: Beta blockers may cause significant bronchial constriction.
Rationale 5: Beta blockers are not contraindicated for use in patients with rheumatoid arthritis.
Global Rationale: Beta blockers may cause hyperglycemia or hypoglycemia and may mask the symptoms of hypoglycemia in patients with diabetes. Beta blockers may cause significant bronchial constriction. While obesity may be contributing to the patient's hypertension, use of propranolol (Inderal) is not contraindicated. Beta blockers are not contraindicated for use in patients with rheumatoid arthritis.
Answer to Question 2
4
Rationale 1: There is no correlation between increased stress, diarrhea, and beta-adrenergic blockers.
Rationale 2: Beta-adrenergic blockers do not affect migraine headaches.
Rationale 3: Having a father who died of a heart attack when he was young is significant but has no correlation to this patient and use of beta-adrenergic blockers.
Rationale 4: With increased doses, beta-adrenergic blockers can slow the heart rate and cause bronchoconstriction . They should be used with caution in patients with asthma.
Global Rationale: With increased doses, beta-adrenergic blockers can slow the heart rate and cause bronchoconstriction . They should be used with caution in patients with asthma. Beta-adrenergic blockers do not affect migraine headaches. Having a father who died of a heart attack when he was young is significant but has no correlation to this patient and use of beta-adrenergic blockers. There is no correlation between increased stress, diarrhea, and beta-adrenergic blockers.